Headquarters
NEXUS DISCOVERY WAY, LEEDS, Leeds LS2 3AA, GB
LEEDS, Leeds, GB
CLOTPROTECT THERAPEUTICS LIMITED
From the company
ClotProtect Therapeutics Limited is a UK therapeutics spin-out from the University of Leeds developing a first-in-class small molecule anti-fibrinolytic (CP-101) to treat acute haemorrhage. The company is currently in preclinical development, aiming to identify a clinical drug candidate, and its approach promotes clot formation through a novel molecule and mechanism with superior efficacy and potency to the current standard of care (TXA).
Products & services offered
Facilities
Send your requirements
Quantities, certifications, and timing.